Delivery Order SPE2DB24D3015-SPE2DB24FFXRP

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,683.97 Firm Fixed Price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 2, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, for providing a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025 and was awarded on February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the supply of NUBEQA 300 MG TABLET 120S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of April 9, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,920.00 and a completion date of February 24, 2025. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of NUBEQA 300 MG Tablets. The $4,683.97 firm fixed price contract has a ceiling value and an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As a key supplier of medical commodities to the U.S. federal government, Amerisourcebergen leverages its extensive distribution network to provide a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,641.98, is for the delivery of the drug NUBEQA 300 MG TABLET 120S. The contract is a firm-fixed price delivery order with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,845.85 firm fixed-price contract is for the delivery of 120 tablets of the prescription drug NUBEQA 300 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a specialty pharmaceutical product. The total ceiling value of the contract is $7,641.98, with a completion date of January 29, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The contract is for the provision of NUBEQA 300 MG TABLET 120S, a specialty pharmaceutical product. The award has a ceiling value of $3,518.40 and a performance period through April 22, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXRP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract is a firm fixed-price delivery order with a ceiling value of $4,683.97 and a period of performance through September 30, 2024. This award is not set aside for any small business designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The company has also been awarded other notable federal contracts, such as a $7,570,000 definitive contract with the Office of the Assistant Secretary for Preparedness and Response for medical supply chain services.

Generated 12/9/24, 1:55 PM